Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

Overview of attention for article published in BMC Gastroenterology, April 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 19,601 followers.

RT @mdmanishshah: And I’m not so sure the benefit of an irinotecan doublet over monotherapy. https://t.co/cHVjU0ZxYp #MedTwitter

Reply Repost Favourite

And I’m not so sure the benefit of an irinotecan doublet over monotherapy. https://t.co/cHVjU0ZxYp #MedTwitter

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.